U.S. Markets closed
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • Dow 30

    33,761.05
    +424.38 (+1.27%)
     
  • Nasdaq

    13,047.19
    +267.27 (+2.09%)
     
  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     
  • Crude Oil

    91.88
    -2.46 (-2.61%)
     
  • Gold

    1,818.90
    +11.70 (+0.65%)
     
  • Silver

    20.83
    +0.49 (+2.39%)
     
  • EUR/USD

    1.0257
    -0.0068 (-0.6565%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • Vix

    19.53
    -0.67 (-3.32%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.5220%)
     
  • USD/JPY

    133.4800
    +0.4810 (+0.3617%)
     
  • BTC-USD

    24,438.41
    +288.02 (+1.19%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Quidel Corporation (QDEL) and Encourages QDEL Shareholders to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

PHILADELPHIA, PA / ACCESSWIRE / December 29, 2021 / Kaskela Law LLC announces that is investigating Quidel Corporation (NASDAQ:QDEL) ("Quidel") on behalf of the Company's shareholders.

On December 23, 2021, Quidel announced that it had entered into a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc ("Ortho") in a cash and stock transaction valued at $6 billion. According to the announcement, Ortho stockholders are expected to receive $24.68 per share ($7.14 in cash and 0.1055 shares of common stock in the combined company) for their Ortho shares, a 25% premium, and are expected to own approximately 38% of the combined company.

Following this announcement, shares of Quidel's common stock declined $28.85 per share, or over 17% in value, to close on December 23, 2021 at $137.39 per share.

The investigation seeks to determine whether Quidel and/or the company's officers and directors violated the securities laws and/or breached their fiduciary duties to QDEL shareholders in connection with the proposed transaction, and whether Quidel shareholders have been harmed as a result.

Quidel shareholders are encouraged to contact Kaskela Law LLC (David Seamus Kaskela, Esq.) at (484) 258 - 1585, or by email (skaskela@kaskelalaw.com) or online at https://kaskelalaw.com/cases/quidel-corporation/, to receive additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

David Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
skaskela@kaskelalaw.com

SOURCE: Kaskela Law LLC



View source version on accesswire.com:
https://www.accesswire.com/680078/SHAREHOLDER-ALERT-Kaskela-Law-LLC-Announces-Investigation-of-Quidel-Corporation-QDEL-and-Encourages-QDEL-Shareholders-to-Contact-the-Firm